NBM is grateful for the support of its private and corporate investors that helped to bring this technology to life.  


Thanks to a first round of funding, NBM is developing its production facilities and will soon be ready to manufacture SPINEREP for the first clinical trial on humans.

Would you like to find out more about potential investment opportunities in this neurotechnology sector? 


Contact us to speak to an investment professional.

Image by Raphaël Biscaldi